|
1
|
Medovic RH, Srejovic IM, Medovic MV, Milosavljevic IM, Nikolic MR, Stojanovic AZ, Kuzmanovic MB, Djurdjevic PM, Bolevich SB, Fisenko VP, Jakovljevic VL, Igrutinovic ZR. Variations of Redox Balance in Different Stages of Childhood Immune Thrombocytopenic Purpura. Thromb Haemost 2023; 123:1129-1139. [PMID: 37604187 DOI: 10.1055/s-0043-1772683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/23/2023]
Abstract
BACKGROUND Few previous studies indicated the role of oxidative stress in the pathogenesis of childhood idiopathic thrombocytopenic purpura (ITP), but there are little data regarding changes in redox balance in different forms of the disease, and changes after therapeutic procedures. We aimed to investigate the values of pro-oxidants and antioxidative capacity in various forms of ITP before and after the applying therapy. MATERIALS AND METHODS The research included 102 children, classified into the following groups: (1) newly diagnosed ITP (ndITP), (2) persistent ITP, (3) chronic ITP (chITP), and (4) control groups: (A) healthy control and (B) previously experienced ITP-healthy children who had been suffering from ITP earlier. During the clinical assessment, a blood sample was taken from the patients, from which the value of pro-oxidants (index of lipid peroxidation measured as TBARS, nitrites [NO2 -], as measurement of nitric oxide [NO] production, superoxide anion radical [O2 -], and hydrogen peroxide [H2O2]) and the capacity of antioxidant protection (activity of superoxide dismutase and catalase, and quantity of reduced glutathione) were determined spectrophotometrically. RESULTS Our results demonstrated that values of pro-oxidants, especially reflected through the TBARS and O2 -, were the highest in the ndITP and exacerbated chITP groups. Also, the activity of the endogenous antioxidative defense system was the lowest in these groups. Intravenous immunoglobulin therapy in the ndITP group exerted the most prominent effect on the redox balance. CONCLUSION It can be concluded that severity and exacerbation of the ITP are closely related to the redox status.
Collapse
Affiliation(s)
- Rasa H Medovic
- Department of Pediatrics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- University Clinical Center Kragujevac, Kragujevac, Serbia
| | - Ivan M Srejovic
- Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- Center of Excellence for the Study of Redox Balance in Cardiovascular and Metabolic Disorders, University of Kragujevac, Kragujevac, Serbia
- Department of Pharmacology, First Moscow State Medical University I.M. Sechenov, Moscow, Russian Federation
| | - Marija V Medovic
- University Clinical Center Kragujevac, Kragujevac, Serbia
- Department of Dermatovenerology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
| | - Isidora M Milosavljevic
- Center of Excellence for the Study of Redox Balance in Cardiovascular and Metabolic Disorders, University of Kragujevac, Kragujevac, Serbia
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
| | - Marina R Nikolic
- Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- Center of Excellence for the Study of Redox Balance in Cardiovascular and Metabolic Disorders, University of Kragujevac, Kragujevac, Serbia
| | - Aleksandra Z Stojanovic
- Center of Excellence for the Study of Redox Balance in Cardiovascular and Metabolic Disorders, University of Kragujevac, Kragujevac, Serbia
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
| | - Milos B Kuzmanovic
- Mother and Child Health Institute of Serbia "Dr Vukan Cupic", Belgrade, Serbia
- Department of Pediatrics, Medical Faculty, University of Belgrade, Belgrade, Serbia
| | - Predrag M Djurdjevic
- University Clinical Center Kragujevac, Kragujevac, Serbia
- Department of Internal medicine, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
| | - Sergey B Bolevich
- Department of Human Pathology, First Moscow State Medical University I.M. Sechenov, Moscow, Russia Federation
| | - Vladimir P Fisenko
- Department of Pharmacology, First Moscow State Medical University I.M. Sechenov, Moscow, Russian Federation
| | - Vladimir Lj Jakovljevic
- Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- Center of Excellence for the Study of Redox Balance in Cardiovascular and Metabolic Disorders, University of Kragujevac, Kragujevac, Serbia
- Department of Human Pathology, First Moscow State Medical University I.M. Sechenov, Moscow, Russia Federation
| | - Zoran R Igrutinovic
- Department of Pediatrics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- University Clinical Center Kragujevac, Kragujevac, Serbia
| |
Collapse
|
|
2
|
Lapshina MA, Shevtsova EF, Grigoriev VV, Aksinenko AY, Ustyugov AA, Steinberg DA, Maleev GV, Dubrovskaya ES, Goreva TV, Epishina TA, Zamoyski VL, Makhaeva GF, Fisenko VP, Veselov IM, Vinogradova DV, Bachurin SO. New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments. Molecules 2023; 28:7567. [PMID: 38005288 PMCID: PMC10673157 DOI: 10.3390/molecules28227567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 10/31/2023] [Accepted: 11/10/2023] [Indexed: 11/26/2023] Open
Abstract
Currently, there are no effective drugs for the treatment of amyotrophic lateral sclerosis (ALS). Only two drugs-edaravone and riluzole-have been approved, but they have very limited efficacy. The aim of this work was to modify the structural core of the Edaravone-phenylpyrazolone moiety and combine it with aminoadamantane pharmacophore in order to expand the spectrum of its action to a number of processes involved in the pathogenesis of ALS. New conjugates of edaravone derivatives with 1-aminoadamantanes combined with alkylene or hydroxypropylene spacers were synthesized, and their biological activity was investigated. Compounds were found that could inhibit lipid peroxidation and calcium-related mitochondrial permeability, block fast sodium currents of CNS neurons, and reduce aggregation of the mutated form of the FUS-protein typical to ALS. So, the proposed modification of the edaravone molecule has allowed the obtaining of new original structures that combine some prospective therapeutic mechanisms against key chains of the pathogenesis of ALS. The identified lead compounds can be used for further optimization and development of new promising drugs on this basis for the treatment of ALS.
Collapse
Affiliation(s)
- Maria A. Lapshina
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Elena F. Shevtsova
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Vladimir V. Grigoriev
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Aleksey Yu. Aksinenko
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Aleksey A. Ustyugov
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Daniil A. Steinberg
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Grigoriy V. Maleev
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Elena S. Dubrovskaya
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Tatiana V. Goreva
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Tatiana A. Epishina
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Vladimir L. Zamoyski
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Galina F. Makhaeva
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Vladimir P. Fisenko
- Department of Pharmacology, Sechenov I. M. First Moscow State Medical University, 8 Build. 2 Trubetskaya Str., 119991 Moscow, Russia;
| | - Ivan M. Veselov
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Daria V. Vinogradova
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| | - Sergey O. Bachurin
- Institute of Physiologically Active Compounds at the Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 1 Severnij proezd, 142432 Chernogolovka, Russia; (M.A.L.); (E.F.S.); (V.V.G.); (A.Y.A.); (A.A.U.); (D.A.S.); (G.V.M.); (E.S.D.); (T.V.G.); (T.A.E.); (V.L.Z.); (G.F.M.); (I.M.V.); (D.V.V.)
| |
Collapse
|
|
3
|
Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Lushchekina SV, Astakhova TY, Timokhina EN, Serebryakova OG, Shchepochkin AV, Averkov MA, Utepova IA, Demina NS, Radchenko EV, Palyulin VA, Fisenko VP, Bachurin SO, Chupakhin ON, Charushin VN, Richardson RJ. Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer's disease. Front Pharmacol 2023; 14:1219980. [PMID: 37654616 PMCID: PMC10466253 DOI: 10.3389/fphar.2023.1219980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 07/18/2023] [Indexed: 09/02/2023] Open
Abstract
We investigated the inhibitory activities of novel 9-phosphoryl-9,10-dihydroacridines and 9-phosphorylacridines against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and carboxylesterase (CES). We also studied the abilities of the new compounds to interfere with the self-aggregation of β-amyloid (Aβ42) in the thioflavin test as well as their antioxidant activities in the ABTS and FRAP assays. We used molecular docking, molecular dynamics simulations, and quantum-chemical calculations to explain experimental results. All new compounds weakly inhibited AChE and off-target CES. Dihydroacridines with aryl substituents in the phosphoryl moiety inhibited BChE; the most active were the dibenzyloxy derivative 1d and its diphenethyl bioisostere 1e (IC50 = 2.90 ± 0.23 µM and 3.22 ± 0.25 µM, respectively). Only one acridine, 2d, an analog of dihydroacridine, 1d, was an effective BChE inhibitor (IC50 = 6.90 ± 0.55 μM), consistent with docking results. Dihydroacridines inhibited Aβ42 self-aggregation; 1d and 1e were the most active (58.9% ± 4.7% and 46.9% ± 4.2%, respectively). All dihydroacridines 1 demonstrated high ABTS•+-scavenging and iron-reducing activities comparable to Trolox, but acridines 2 were almost inactive. Observed features were well explained by quantum-chemical calculations. ADMET parameters calculated for all compounds predicted favorable intestinal absorption, good blood-brain barrier permeability, and low cardiac toxicity. Overall, the best results were obtained for two dihydroacridine derivatives 1d and 1e with dibenzyloxy and diphenethyl substituents in the phosphoryl moiety. These compounds displayed high inhibition of BChE activity and Aβ42 self-aggregation, high antioxidant activity, and favorable predicted ADMET profiles. Therefore, we consider 1d and 1e as lead compounds for further in-depth studies as potential anti-AD preparations.
Collapse
Affiliation(s)
- Galina F. Makhaeva
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
| | - Nadezhda V. Kovaleva
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
| | - Elena V. Rudakova
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
| | - Natalia P. Boltneva
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
| | - Sofya V. Lushchekina
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
- Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia
| | - Tatiana Yu Astakhova
- Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia
| | - Elena N. Timokhina
- Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russia
| | - Olga G. Serebryakova
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
| | - Alexander V. Shchepochkin
- Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia
- Department of Organic and Biomolecular Chemistry, Ural Federal University, Yekaterinburg, Russia
| | - Maxim A. Averkov
- Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia
- Department of Organic and Biomolecular Chemistry, Ural Federal University, Yekaterinburg, Russia
| | - Irina A. Utepova
- Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia
- Department of Organic and Biomolecular Chemistry, Ural Federal University, Yekaterinburg, Russia
| | - Nadezhda S. Demina
- Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia
| | - Eugene V. Radchenko
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia
| | - Vladimir A. Palyulin
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
- Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia
| | - Vladimir P. Fisenko
- Department of Pharmacology of the Institute of Biodesign and Complex System Modeling of Biomedical Science & Technology Park of Sechenov I.M., First Moscow State Medical University, Moscow, Russia
| | - Sergey O. Bachurin
- Institute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Russia
| | - Oleg N. Chupakhin
- Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia
- Department of Organic and Biomolecular Chemistry, Ural Federal University, Yekaterinburg, Russia
| | - Valery N. Charushin
- Institute of Organic Synthesis, Russian Academy of Sciences, Yekaterinburg, Russia
- Department of Organic and Biomolecular Chemistry, Ural Federal University, Yekaterinburg, Russia
| | - Rudy J. Richardson
- Department of Pharmacology of the Institute of Biodesign and Complex System Modeling of Biomedical Science & Technology Park of Sechenov I.M., First Moscow State Medical University, Moscow, Russia
- Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, United States
- Department of Neurology, University of Michigan, Ann Arbor, MI, United States
- Center of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States
| |
Collapse
|
|
4
|
Moshetova LK, Soshina MM, Turkina KI, Grishina EA, Sozaeva ZA, Kachanova AA, Akmalova KA, Ivashchenko DV, Zastrozhin MS, Fisenko VP, Sychev DA. Effect of CYP2D6*4, CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma. Drug Metab Pers Ther 2023; 38:143-148. [PMID: 36001461 DOI: 10.1515/dmpt-2022-0117] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Accepted: 05/30/2022] [Indexed: 06/07/2023]
Abstract
OBJECTIVES Timolol maleate is used for the treatment of glaucoma and metabolized by cytochrome CYP2D6 in the liver. The aim of this study was the evaluation of the influence of CYP2D6*4 and CYP2D6*10 gene polymorphisms on the safety of medications containing 0.5% of timolol maleate as glaucoma treatment in patients with primary open-angle glaucoma (POAG). METHODS 105 patients with POAG were prescribed glaucoma medications, containing 0.5% timolol maleate. The safety of glaucoma treatment was determined by electrocardiography (ECG) (to assess heart rate (HR) and PQ interval) and blood pressure (BP) measurements. The real-time polymerase chain reaction method was used for the detection of single nucleotide polymorphisms (SNP). RESULTS The risk of adverse drug reactions was higher in patients with the CYP2D6*4 GA genotype compared with GG: mean HR change at 1 month (2.88 ± 4.68 and 6.44 ± 5.57, p<0.001) and 6 months (5.14 ± 8.93 and 7.88 ± 5.65, p<0.001), mean PQ interval change at 1 (0.01 ± 0.031 and 0.02 ± 0.022, p=0.003) and 6 months (0.01 ± 0.032 and 0.02 ± 0.024, p=0.003). The risk of adverse drug reactions was higher in patients with the CYP2D6*10 CT genotype compared with CC: mean HR change at 1 month (2.94 ± 4.65 and 6.34 ± 5.66, p<0.001) and 6 months (5.20 ± 8.90 and 7.78 ± 5.75, p<0.001), mean PQ interval change at 1 (0.01 ± 0.032 and 0.02 ± 0.021, p=0.014) and 6 months (0.01 ± 0.033 and 0.02 ± 0.022, p=0.014). CONCLUSIONS CYP2D6*4 and CYP2D6*10 gene polymorphisms may affect a higher risk of timolol-induced bradycardia and increased PQ interval of treatment medications containing 0.5% of timolol maleate in patients with POAG.
Collapse
Affiliation(s)
- Larisa K Moshetova
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Maria M Soshina
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Ksenia I Turkina
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Elena A Grishina
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Zhannet A Sozaeva
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Anastasia A Kachanova
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Kristina A Akmalova
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Dmitriy V Ivashchenko
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
- Penza Branch of Russian Medical Academy of Continuous Professional Education, Penza, Russian Federation
| | - Mikhail S Zastrozhin
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Vladimir P Fisenko
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
| | - Dmitry A Sychev
- Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| |
Collapse
|
|
5
|
Sinitsina II, Boyarko AV, Temirbulatov II, Sychev DA, Akmalova KA, Sozaeva ZA, Grishina EA, Mirzaev KB, Asoskova AV, Fisenko VP. CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study. Drug Metab Pers Ther 2022:dmdi-2022-0115. [PMID: 36580432 DOI: 10.1515/dmpt-2022-0115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 11/22/2022] [Indexed: 12/30/2022]
Abstract
OBJECTIVES CYP2C9 gene polymorphic variants can decrease the effects of losartan, reducing active metabolite (E-3174) formation. Study aims to determine the influence of *2 (+430C>T; rs799853) and *3 (+1075A>C; rs1057910) CYP2C9 gene polymorphic variants on the hypotensive and uricosuric effect of losartan on patients with arterial hypertension. METHODS Eighty one patients with stage 1-2 arterial hypertension newly diagnosed with ABMP were enrolled in the study. Physicians started losartan treatment and then we measured urine concentration of E-3174/losartan to estimate CYP2C9 activity. After 3-month losartan treatment we compared effectiveness of the therapy with ABPM and plasma uric acid level between carriers of CYP2C9 *1/*1 and CYP2C9 gene polymorphic variants (*2 and *3). RESULTS Carriage of CYP2C9*2 and CYP2C9*3 alleles reduced the hypotensive effect of losartan (p<0.001, OR=8.13 (95% CI, 2.75-23.97)). Analysis of the ABPM data revealed that blood pressure was significantly higher in patients with polymorphic genotypes. There was no significant difference in uric acid level in plasma and losartan and its metabolite concentration in urine between genotypes. CONCLUSIONS Carriage of low function polymorphic variants of the CYP2C9 gene (*2 and *3) reduced the hypotensive effect of losartan according to ABPM and don't affect uric acid level in plasma and E-3174/losartan in urine.
Collapse
Affiliation(s)
- Irina I Sinitsina
- Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Alexey V Boyarko
- Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Ilyas I Temirbulatov
- Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation.,Laboratory of Human Population Genetics, Research Centre for Medical Genetics, Moscow, Russia
| | - Dmitry A Sychev
- Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Kristina A Akmalova
- Department of Molecular Medicine, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Zhannet A Sozaeva
- Department of Molecular Medicine, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Elena A Grishina
- Department of Molecular Medicine, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Karin B Mirzaev
- Laboratory of Human Population Genetics, Research Centre for Medical Genetics, Moscow, Russia.,Department of Molecular Medicine, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Anastasiia V Asoskova
- Department of Dermatovenerology and Cosmetology, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
| | - Vladimir P Fisenko
- Department of Pharmacology, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
| |
Collapse
|
|
6
|
Sobot NM, Sobot TS, Jeremic JN, Bolevich SB, Bolevich SS, Mitrovic SL, Fisenko VP, Inic SG, Samanovic ADM, Rankovic MR, Srejovic IM, Zivkovic VI, Jakovljevic VL. Minocycline as heart conditioning agent in experimental type 2 diabetes mellitus - an antibacterial drug in heart protection. Naunyn Schmiedebergs Arch Pharmacol 2022; 395:429-444. [PMID: 35113200 DOI: 10.1007/s00210-021-02179-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Accepted: 11/05/2021] [Indexed: 11/25/2022]
Abstract
Cardiovascular diseases, and among them certainly myocardial infarction, remain leading cause of death worldwide. Diabetes increases risk of occurrence as well as adverse outcome of myocardial infarction. Conditioning maneuvers are the most attractive method for alleviating both the consequences of ischemia and reperfusion. Minocycline is a tetracycline derivative which exerts antioxidant, anti-inflammatory, and anti-apoptotic effects. The aim of this study was to assess the protective ability of preconditioning and postconditioning of isolated hearts from healthy and rats with experimentally induced type 2 diabetes with minocycline on functional recovery and redox status after ischemia and reperfusion. The hearts from healthy and diabetic rats were excised and retrogradely perfused according to the Langendorff technique. Using sensor in the left ventricle, the cardiodynamic parameters were recorded and in the samples of the coronary venous effluent oxidative stress biomarkers were analyzed. Minocycline was injected directly into the coronary vessels, in preconditioning 5 min before global ischemia, and in postconditioning during the first 5 min of reperfusion. Results of this study clearly show beneficial effects of minocycline applied both before ischemia and in the first minutes of reperfusion fashion in both healthy and diabetic rat hearts. The most prominent protective effect regarding oxidative stress is related to the decreased production of superoxide anion radical due postconditioning with minocycline in diabetic hearts. Cardiodynamic parameters were significantly improved in minocycline conditioned groups. Superoxide anion radical stands out as the most susceptible to changes induced by minocycline.
Collapse
Affiliation(s)
- Nikola M Sobot
- Clinic for Cardiac Surgery, University Clinical Centre of the Republic of Srpska, Dvanaest beba st. bb, 78000, Banja Luka, Bosnia and Herzegovina
| | - Tanja S Sobot
- Department of Physiology, University of Banja Luka, Save Mrkalja st. 14, 78000, Banja Luka, Bosnia and Herzegovina
| | - Jovana N Jeremic
- Department of Pharmacy, University of Kragujevac, Svetozara Markovica st. 69, 34000, Kragujevac, Serbia
| | - Sergey B Bolevich
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University, Trubetskaya st. 8, Moscow, 119991, Russia
| | - Stefani S Bolevich
- Department of Pathophysiology, I.M. Sechenov First Moscow State Medical University (Sechenov University, Trubetskaya st. 8, Moscow, 119991, Russia
- Department of Pharmacology, I.M. Sechenov First Moscow State Medical University (Sechenov University, Trubetskaya st. 8, Moscow, 119991, Russia
| | - Slobodanka Lj Mitrovic
- Department of Pathology, University of Kragujevac, Svetozara Markovica st. 69, 34000, Kragujevac, Serbia
| | - Vladimir P Fisenko
- Department of Pharmacology, I.M. Sechenov First Moscow State Medical University (Sechenov University, Trubetskaya st. 8, Moscow, 119991, Russia
| | - Sofija G Inic
- University of Pristina With Temporary Headquarters in Kosovksa Mitrovica Anri Dinana St. Bb, 38220, Kosovska Mitrovica, Serbia
| | | | - Marina R Rankovic
- Department of Physiology, University of Kragujevac, Svetozara Markovica st. 69, 34000, Kragujevac, Serbia
| | - Ivan M Srejovic
- Department of Physiology, University of Kragujevac, Svetozara Markovica st. 69, 34000, Kragujevac, Serbia
| | - Vladimir I Zivkovic
- Department of Physiology, University of Kragujevac, Svetozara Markovica st. 69, 34000, Kragujevac, Serbia
| | - Vladimir Lj Jakovljevic
- Department of Human Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University, Trubetskaya st. 8, Moscow, 119991, Russia.
- Department of Physiology, University of Kragujevac, Svetozara Markovica st. 69, 34000, Kragujevac, Serbia.
| |
Collapse
|
|
7
|
Kseneva SI, Borodulina EV, Trifonova OY, Fisenko VP, Udut VV. Comparative Informativity of Computing Methods of Insulin Resistance Assessment. Bull Exp Biol Med 2022; 172:385-389. [PMID: 35001303 DOI: 10.1007/s10517-022-05398-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Indexed: 11/28/2022]
Abstract
We conducted a comparative study of the calculated indices of insulin resistance HOMA-R, Caro, FGIR, and QUICKI in 29 healthy volunteers (mean age 26.21±0.93 years) with normal body mass index (23.34±0.55 kg/m2). Among the used methods for insulin resistance assessment, QUICKI is the only method that has characteristics required for the diagnostic criterium: low variability coefficient, 100% reproducibility, and minimum coefficient of variation.
Collapse
Affiliation(s)
- S I Kseneva
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
| | - E V Borodulina
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
| | - O Yu Trifonova
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
| | - V P Fisenko
- I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
| | - V V Udut
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.,National Research Tomsk State University, Tomsk, Russia
| |
Collapse
|
|
8
|
Makhaeva GF, Lushchekina SV, Kovaleva NV, Yu Astakhova T, Boltneva NP, Rudakova EV, Serebryakova OG, Proshin AN, Serkov IV, Trofimova TP, Tafeenko VA, Radchenko EV, Palyulin VA, Fisenko VP, Korábečný J, Soukup O, Richardson RJ. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment. Bioorg Chem 2021; 112:104974. [PMID: 34029971 DOI: 10.1016/j.bioorg.2021.104974] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2021] [Revised: 04/24/2021] [Accepted: 05/03/2021] [Indexed: 02/06/2023]
Abstract
We synthesized eleven new amiridine-piperazine hybrids 5a-j and 7 as potential multifunctional agents for Alzheimer's disease (AD) treatment by reacting N-chloroacetylamiridine with piperazines. The compounds displayed mixed-type reversible inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Conjugates were moderate inhibitors of equine and human BChE with negligible fluctuation in anti-BChE activity, whereas anti-AChE activity was substantially dependent on N4-substitution of the piperazine ring. Compounds with para-substituted aromatic moieties (5g, 5h, and bis-amiridine 7) had the highest anti-AChE activity in the low micromolar range. Top-ranked compound 5h, N-(2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinolin-9-yl)-2-[4-(4-nitro-phenyl)-piperazin-1-yl]-acetamide, had an IC50 for AChE = 1.83 ± 0.03 μM (Ki = 1.50 ± 0.12 and αKi = 2.58 ± 0.23 μM). The conjugates possessed low activity against carboxylesterase, indicating a likely absence of unwanted drug-drug interactions in clinical use. In agreement with analysis of inhibition kinetics and molecular modeling studies, the lead compounds were found to bind effectively to the peripheral anionic site of AChE and displace propidium, indicating their potential to block AChE-induced β-amyloid aggregation. Similar propidium displacement activity was first shown for amiridine. Two compounds, 5c (R = cyclohexyl) and 5e (R = 2-MeO-Ph), exhibited appreciable antioxidant capability with Trolox equivalent antioxidant capacity values of 0.47 ± 0.03 and 0.39 ± 0.02, respectively. Molecular docking and molecular dynamics simulations provided insights into the structure-activity relationships for AChE and BChE inhibition, including the observation that inhibitory potencies and computed pKa values of hybrids were generally lower than those of the parent molecules. Predicted ADMET and physicochemical properties of conjugates indicated good CNS bioavailability and safety parameters comparable to those of amiridine and therefore acceptable for potential lead compounds at the early stages of anti-AD drug development.
Collapse
Affiliation(s)
- Galina F Makhaeva
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia
| | - Sofya V Lushchekina
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia; Emanuel Institute of Biochemical Physics Russian Academy of Sciences, Moscow 119334, Russia
| | - Nadezhda V Kovaleva
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia
| | - Tatiana Yu Astakhova
- Emanuel Institute of Biochemical Physics Russian Academy of Sciences, Moscow 119334, Russia
| | - Natalia P Boltneva
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia
| | - Elena V Rudakova
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia
| | - Olga G Serebryakova
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia
| | - Alexey N Proshin
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia
| | - Igor V Serkov
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia
| | - Tatiana P Trofimova
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia; Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia
| | - Victor A Tafeenko
- Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia
| | - Eugene V Radchenko
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia; Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia
| | - Vladimir A Palyulin
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka 142432, Russia; Department of Chemistry, Lomonosov Moscow State University, Moscow 119991, Russia
| | - Vladimir P Fisenko
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119881, Russia
| | - Jan Korábečný
- Biomedical Research Centre, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic
| | - Ondrej Soukup
- Biomedical Research Centre, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic
| | - Rudy J Richardson
- Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI 48109 USA; Department of Neurology, University of Michigan, Ann Arbor, MI 48109 USA; Center of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109 USA.
| |
Collapse
|
|
9
|
Herrera AS, Solís Arias PE, Esparza MDCA, Bernal LFT, Bondarev AD, Fisenko VP, Chubarev VN, Minyaeva NN, Mikhaleva LM, Tarasov VV, Somasundaram SG, Kirkland CE, Aliev G. The Long-Term Effect of Medically Enhancing Melanin Intrinsic Bioenergetics Capacity in Prematurity. Curr Genomics 2020; 21:525-530. [PMID: 33214768 PMCID: PMC7604751 DOI: 10.2174/1389202921999200417172817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2019] [Revised: 08/09/2019] [Accepted: 03/16/2020] [Indexed: 11/22/2022] Open
Abstract
Background The ability of the human body to produce metabolic energy from light modifies fundamental concepts of biochemistry. Objective This review discusses the relationships between the long-accepted concept is that glucose has a unique dual role as an energy source and as the main source of carbon chains that are precursors of all organic matter. The capability of melanin to produce energy challenges this premise. Methods The prevalent biochemical concept, therefore, needs to be adjusted to incorporate a newly discovered state of Nature based on melanin's ability to dissociate water to produce energy and to re-form water from molecular hydrogen and oxygen. Results and Discussion Our findings regarding the potential implication of QIAPI-1 as a melanin precursor that has bioenergetics capabilities. Conclusion Specifically, we reported its promising application as a means for treating retinopathy of prematurity (ROP). The instant report focuses on the long-term treatment medical effects of melanin in treating ROP.
Collapse
Affiliation(s)
- Arturo S Herrera
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Paola E Solís Arias
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - María Del C A Esparza
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Luis F T Bernal
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Andrey D Bondarev
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Vladimir P Fisenko
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Vladimir N Chubarev
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Nina N Minyaeva
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Liudmila M Mikhaleva
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Vadim V Tarasov
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Siva G Somasundaram
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Cecil E Kirkland
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| | - Gjumrakch Aliev
- 1Human Photosynthesis Study Centre, Aguascalientes, Mexico; 2Universidad Autónoma de Aguascalientes, Aguascalientes, Ags., Mexico; 3Asociación para Evitar la Ceguera en México, I.A.P., Mexico City, Mexico; 4I. M. Seche-nov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation; 5National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow101000, Russian Federation; 6Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow117418, Russian Federation; 7Department of Biological Sciences, Salem University, Salem, WV, USA; 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences, Chernogolovka, Russia; 9GALLY International Research Institute, San Antonio, TX- 78229, USA
| |
Collapse
|
|
10
|
Muresanu C, Somasundaram SG, Neganova ME, Bovina EV, Vissarionov SV, Ofodile ONFC, Fisenko VP, Bragin V, Minyaeva NN, Chubarev VN, Klochkov SG, Tarasov VV, Mikhaleva LM, Kirkland CE, Aliev G. Updated Understanding of the Degenerative Disc Diseases - Causes Versus Effects - Treatments, Studies and Hypothesis. Curr Genomics 2020; 21:464-477. [PMID: 33093808 PMCID: PMC7536794 DOI: 10.2174/1389202921999200407082315] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Revised: 08/20/2019] [Accepted: 03/16/2020] [Indexed: 01/22/2023] Open
Abstract
Background In this review we survey medical treatments and research strategies, and we discuss why they have failed to cure degenerative disc diseases or even slow down the degenerative process. Objective We seek to stimulate discussion with respect to changing the medical paradigm associated with treatments and research applied to degenerative disc diseases. Method Proposal We summarize a Biological Transformation therapy for curing chronic inflammations and degenerative disc diseases, as was previously described in the book Biological Transformations controlled by the Mind Volume 1. Preliminary Studies A single-patient case study is presented that documents complete recovery from an advanced lumbar bilateral discopathy and long-term hypertrophic chronic rhinitis by application of the method proposed. Conclusion Biological transformations controlled by the mind can be applied by men and women in order to improve their quality of life and cure degenerative disc diseases and chronic inflammations illnesses.
Collapse
Affiliation(s)
- Cristian Muresanu
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Siva G Somasundaram
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Margarita E Neganova
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Elena V Bovina
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Sergey V Vissarionov
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Okom N F C Ofodile
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Vladimir P Fisenko
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Valentin Bragin
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Nina N Minyaeva
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Vladimir N Chubarev
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Sergey G Klochkov
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Vadim V Tarasov
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Liudmila M Mikhaleva
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Cecil E Kirkland
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| | - Gjumrakch Aliev
- 1Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania; 2Department of Biological Sciences, Salem University, Salem, WV, USA; 3Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russia; 4Department of Spinal Pathology and Neurosurgery, Turner Scientific and Research Institute for Children's Orthopedics, Street Parkovskya 64-68, Pushkin, Saint-Petersburg, 196603, Russia; 5Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charite, Universitaetsmedizin Berlin, AG: Theuring, Hessische Strasse 2-4, D-10115Berlin, Germany, 6Obie-Medical Corporate International LTD., Academic Section, 28 Oranye Street (American Quarters), Onitsha, Anambra State, Nigeria; 7I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russia; 8Stress Relief and Memory Training Center, 3101 Ocean Pkwy, Suite 1A, Brooklyn, NY, 11235, USA; 9National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russia; 10Research Institute of Human Morphology, 3, Tsyurupy Str., Moscow, 117418, Russia; 11GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX78229, USA
| |
Collapse
|
|
11
|
Abstract
The article presents data on the mechanism of various approaches of drug-induced myopia control and their potential effectiveness, and analyses promising options for medicated correction of myopia.
Collapse
Affiliation(s)
- S E Avetisov
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.,Research Institute of Eye Diseases, Moscow, Russia
| | - V P Fisenko
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
| | - A S Zhuravlev
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
| | - L M Agaeva
- Research Institute of Eye Diseases, Moscow, Russia
| |
Collapse
|
|
12
|
Bykov VV, Leonov KA, Serebrov VY, Chernysheva GA, Smol'yakova VI, Solov'ev MA, Udut EV, Fisenko VP, Udut VV. Metabolism of a New Antiaggregant, Indolinone Derivative. Bull Exp Biol Med 2020; 168:739-742. [PMID: 32333310 DOI: 10.1007/s10517-020-04792-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2019] [Indexed: 11/26/2022]
Abstract
Cytochrome p450-mediated metabolism of GRS (indolinone antiaggregant) and its effects on activities of cytochrome p450 isoenzymes were studied. Inhibition of 6 isomers of cytochrome p450 in human liver microsomes was studied with the use of specific substrates. It was found that human liver cytochrome p450 enzymes could not induce degradation of GRS and that GRS was not an inductor or inhibitor of cytochrome p450 family members 1A2, 2C9, 2C19, 2D6, 2C8, and 3A4. Hence, clinical use of the prospective antiaggregant would not involve the risk of uncontrolled fluctuations in GRS concentrations in the organism because of interactions between the drugs.
Collapse
Affiliation(s)
- V V Bykov
- Siberean State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
- Innovation Pharmacological Development, Moscow, Russia.
| | - K A Leonov
- Innovation Pharmacological Development, Moscow, Russia
| | - V Yu Serebrov
- Siberean State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - G A Chernysheva
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
| | - V I Smol'yakova
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
| | - M A Solov'ev
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
- National Research Tomsk State University, Tomsk, Russia
| | - E V Udut
- Siberean State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
| | - V P Fisenko
- I. M. Se- chenov First Moscow State Medical University, Ministry of Heath of the Russian Federation (Sechenov University), Moscow, Russia
| | - V V Udut
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
- National Research Tomsk State University, Tomsk, Russia
| |
Collapse
|
|
13
|
Kotlovskiy MY, Udut EV, Kairov GT, Fisenko VP, Udut VV. Effects of Simvastatin on the Metabolism of Fatty Acids in Combined Secondary Prevention of Coronary Heart Disease: Dosage and Gender Differences between the Effects. Cardiovasc Hematol Disord Drug Targets 2020; 20:93-107. [PMID: 31916523 DOI: 10.2174/1871529x20666200109144353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2018] [Revised: 11/12/2019] [Accepted: 11/26/2019] [Indexed: 11/22/2022]
Abstract
BACKGROUND Statins are currently used for secondary prevention of Coronary Heart Disease (CHD), as the lipid-lowering therapy with them is proven safe and effective. OBJECTIVE The purpose of this research is to investigate the dose-dependent effect of statins used for secondary prevention of coronary heart disease, as well as mechanisms of quantitative and qualitative changes in lipoproteins, fatty acids and cholesterol in the blood and tissues of people of both sexes. METHODS In a clinical trial (n=125, of which 89 patients belong to group 1 and 36 to group 2) and an experiment on laboratory animals (n = 100), simvastatin reduced the total level of fatty acids in blood plasma, when given in the amount that was within the therapeutic dose range. RESULTS This effect was achieved through a drug-induced improvement in the capacity of hepatic cells to absorb Low-density (LDL) and Very-low-density (VLDL) lipoproteins. CONCLUSION Considering the formation of saturated fatty acids, statin performed better in males. With Omega-3 polyunsaturated fatty acids involved, changes in lipoproteins, cholesterol and fatty acids (liver and myocardium) were similar to those caused by small doses of a statin drug. Effects of the combination of bisoprolol and acetylsalicylic acid were completely different from those caused by the use of statin.
Collapse
Affiliation(s)
- Mikhail Y Kotlovskiy
- Laboratory of Drug Toxicology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center of the Russian Academy of Science, Tomsk, Russian Federation.,Laboratory of Drug Toxicology, National Research Tomsk State University, Tomsk, Russian Federation
| | - Elena V Udut
- Central Research Laboratory, Siberian State Medical University, Tomsk, Russian Federation
| | - Gaisa T Kairov
- Central Research Laboratory, Siberian State Medical University, Tomsk, Russian Federation
| | - Vladimir P Fisenko
- Department Pharmacology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
| | - Vladimir V Udut
- Laboratory of Drug Toxicology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center of the Russian Academy of Science, Tomsk, Russian Federation.,Laboratory of Drug Toxicology, National Research Tomsk State University, Tomsk, Russian Federation
| |
Collapse
|
|
14
|
Popova EP, Bogova OT, Puzin SN, Sychev DA, Fisenko VP. [Drug therapy of atrial fibrillation in elderly patients.]. Adv Gerontol 2020; 33:539-548. [PMID: 33280340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Currently, studies of the causes of atrial fibrillation are actively conducted. However, molecular and cellular mechanisms of atrial fibrillation have not been precisely established so far. Great success in the treatment of atrial fibrillation was achieved thanks to the development of surgical methods. However, these approaches, unfortunately, are not always applicable to elderly and senile patients. Antiarrhythmic drugs used in atrial fibrillation, exhibit a large number of side effects. Much attention of researchers is now attracted by fundamentally new directions in the drug treatment of atrial fibrillation. These include predserdno-selective antifibrillatory funds. Drugs, the action of which is aimed at at atrial remodeling, inflammation and fibrosis, so is of interest. Effective suppression of atrial remodeling, inflammation and fibrosis prevents the formation of a permanent form of atrial fibrillation. A new approach to the treatment of atrial fibrillation, taking into account the vegetative status of the patient, will undoubtedly increase its effectiveness.
Collapse
Affiliation(s)
- E P Popova
- I.M.Sechenov First Moscow State Medical University, 8 build. 2 Trubetskaya str., Moscow 119991, Russian Federation, e-mail:
| | - O T Bogova
- Russian Medical Academy of Continuous Professional Education, 2 build. 1 Barrikadnaya str., Moscow 125993, Russian Federation
| | - S N Puzin
- I.M.Sechenov First Moscow State Medical University, 8 build. 2 Trubetskaya str., Moscow 119991, Russian Federation, e-mail:
- Russian Medical Academy of Continuous Professional Education, 2 build. 1 Barrikadnaya str., Moscow 125993, Russian Federation
- Federal Scientific-Clinical Center of Emergency Medicine and Rehabilitation, 777 Lytkino village, Solnechnogorsky district, Moscow region 141534, Russian Federation
| | - D A Sychev
- Russian Medical Academy of Continuous Professional Education, 2 build. 1 Barrikadnaya str., Moscow 125993, Russian Federation
| | - V P Fisenko
- I.M.Sechenov First Moscow State Medical University, 8 build. 2 Trubetskaya str., Moscow 119991, Russian Federation, e-mail:
| |
Collapse
|
|
15
|
Herrera AS, Arias PES, del Carmen Arias Esparza M, Torres Bernal LF, Bondarev AD, Fisenko VP, Chubarev VN, Minyaeva NN, Mikhaleva LM, Tarasov VV, Somasundaram SG, Kirkland CE, Aliev G. Notice of Withdrawal. Curr Top Med Chem 2019; 19:CTMC-EPUB-102353. [PMID: 31724499 DOI: 10.2174/1568026619666191114110928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2019] [Revised: 09/05/2019] [Accepted: 10/10/2019] [Indexed: 11/22/2022]
Abstract
Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php Bentham Science Disclaimer it is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Collapse
Affiliation(s)
| | | | | | | | - Andrey D. Bondarev
- I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation
| | - Vladimir P. Fisenko
- I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation
| | - Vladimir N. Chubarev
- I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University),Moscow, Russian Federation
| | - Nina N. Minyaeva
- National Research University Higher School of Economics, 20 Myasnitskaya Street, Moscow, 101000, Russian Federation
| | - Lyudmila M. Mikhaleva
- Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow, 117418, Russian Federation
| | - Vadim V. Tarasov
- I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation
| | | | - Cecil E. Kirkland
- Department of Biological Sciences, Salem University, Salem, WV, United States
| | - Gjumrakch Aliev
- I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation
| |
Collapse
|
|
16
|
Kokhan VS, Kokhan TYG, Samsonova AN, Fisenko VP, Ustyugov AA, Aliev G. The Dopaminergic Dysfunction and Altered Working Memory Performance of Aging Mice Lacking Gamma-synuclein Gene. CNS Neurol Disord Drug Targets 2019; 17:604-607. [PMID: 30047337 DOI: 10.2174/1871527317666180726095734] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/06/2017] [Revised: 05/08/2018] [Accepted: 07/18/2018] [Indexed: 11/22/2022]
Abstract
BACKGROUND It was previously shown that inactivation of gamma-synuclein which is a small soluble neuronal protein affects psycho-emotional status and cognitive abilities in knock-out mice. OBJECTIVE Determine the role of gamma-synuclein inactivation on memory performance in aging animals. METHOD We used the passive avoidance test and acute amphetamine administration in aging gammasynuclein knock-out mice. RESULTS As a result, we found moderate aging-unlinked deficit of dopaminergic neurotransmitter system of gamma-synuclein knock-out mice. At the same time, the evidence of progressive synaptic vesicle trafficking machinery impairment was obtained. CONCLUSION Therefore most likely these dysfunctions are associated with a reduction in the highefficient learning performance in tests that require intact working memory.
Collapse
Affiliation(s)
- Viktor S Kokhan
- Institute of Biomedical Problems RAS, Moscow, Russian Federation
| | - Tat Yana G Kokhan
- Specialized Multidisciplinary Hospital №1 of Ukrainian Ministry of Health, Dnipro, Ukraine
| | - Anna N Samsonova
- Institute of Physiologically Active Compounds RAS, Chernogolovka, Russian Federation
| | - Vladimir P Fisenko
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation
| | - Aleksey A Ustyugov
- Institute of Physiologically Active Compounds RAS, Chernogolovka, Russian Federation
| | - Gjumrakch Aliev
- Institute of Physiologically Active Compounds RAS, Chernogolovka, Russian Federation.,I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation.,School of Health Science and Healthcare Administration, University of Atlanta, Johns Creek, Georgia, United States
| |
Collapse
|
|
17
|
Herrera AS, A Esparza MDC, Arias PES, Ashraf GM, Mosa OF, Fisenko VP, Sologova SS, Dostdar SA, Sokolov AV, Bovina EV, Chubarev VN, Tarasov VV, Somasundaram SG, Kirkland CE, Aliev G. The Role of Melanin to Dissociate Oxygen from Water to Treat Retinopathy of Prematurity. Cent Nerv Syst Agents Med Chem 2019; 19:215-222. [PMID: 31267880 DOI: 10.2174/1871524919666190702164206] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2019] [Revised: 06/14/2019] [Accepted: 06/17/2019] [Indexed: 11/22/2022]
Abstract
BACKGROUND Retinopathy of Prematurity (ROP) is a potentially blinding disorder that commonly afflicts premature infants who are born prior to 31weeks of gestation or with a body weight less than 1250 grams (about 2.75 pounds). Another risk factor is excessive oxygen in incubators, which can lead to blindness. A compounding factor is that survival rates for premature infants are rising with concomitantly more cases of ROP. We have reported an unsuspected intrinsic property of melanin to dissociate water. This capability can be considered an alternative treatment option for adult and neonatal diseases. It is known that exogenous surfactant administration suppresses bronchopulmonary dysplasia and consequent death, randomized, controlled trials with various respiratory interventions did not show any significant reductions in morbidity and mortality rates. During a descriptive study about the three leading causes of blindness in the world, the ability of melanin to transform light energy into chemical energy through the dissociation of water molecule was unraveled. Initially, during 2 or 3 years; we tried to link together our findings with the widely accepted metabolic pathways already described in molecular pathway databases, which have been developed to collect and organize the current knowledge on metabolism scattered across a multitude of scientific evidence. OBSERVATIONS The current report demonstrates the main problems that afflict premature babies with an emphasis on the growth of abnormal vessels in the retina, the explanation for which is unknown until date. We also reported a case of a baby who suffered digestive and respiratory problems with a brain haemorrhage that was successfully treated by laser photocoagulation. We hypothesise that most likely this effect was due to the melanin level and melanin itself produces oxygen via dissociating with water molecules. CONCLUSION We postulate that the intrinsic effect of melanin may easily convert visible and invisible light into chemical energy via a water dissociation reaction similar to the one in plant's chlorophyll, and markedly elevated with diagnosis and treatment of the complications related to premature babies.
Collapse
Affiliation(s)
- Arturo S Herrera
- Human Photosynthesis® Study Center. Sierra del Laurel 212, Bosques del Prado Norte, Aguascalientes, CP 20000, Mexico
| | - María Del Carmen A Esparza
- Human Photosynthesis® Study Center. Sierra del Laurel 212, Bosques del Prado Norte, Aguascalientes, CP 20000, Mexico
| | - Paola E S Arias
- Human Photosynthesis® Study Center. Sierra del Laurel 212, Bosques del Prado Norte, Aguascalientes, CP 20000, Mexico
| | - Ghulam M Ashraf
- King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Osama F Mosa
- Health Sciences College at Leith, UQU, Saudi Arabia
| | - Vladimir P Fisenko
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation
| | - Susanna S Sologova
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation
| | - Samira A Dostdar
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation
| | - Alexander V Sokolov
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation
| | - Elena V Bovina
- Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation
| | - Vladimir N Chubarev
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation
| | - Vadim V Tarasov
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation
| | - Siva G Somasundaram
- Department of Biological Sciences, Salem University, Salem, WV, United States
| | - Cecil E Kirkland
- Department of Biological Sciences, Salem University, Salem, WV, United States
| | - Gjumrakch Aliev
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, bld. 2, Moscow, 119991, Russian Federation.,Institute of Physiologically Active Compounds Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation.,GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX, 78229, United States
| |
Collapse
|
|
18
|
Abstract
Objective. Specific activity of an antiplatelet drug of indolinone series (codenamed DI) was studied in vitro in a model of ADP-induced platelet aggregation in vitro and in vivo in a model of streptozotocininduced diabetes mellitus in rats.
Material and Methods. Acetylsalicylic acid and dipyridamole were used as reference drugs. In vitro tests have demonstrated that DI exhibits antiplatelet activity in a wide range of concentrations (0,75×10-6 – 1.5×10-5 М, р<0,05), being comparable to acetylsalicylic acid and dipyridamole. In vivo tests have demonstrated dose-dependent antiplatelet activity of DI in doses of 2,5 – 20 mg/kg (21-14 %).
Results and Discussion.Increasing the dose of DI above 10 mg/kg doesn’t increase its antiplatelet activity. After multiple oral administration to rats with streptozotocin-induced diabetes mellitus in 10 mg/kg dose, DI has exhibited antiplatelet activity, reducing the platelet aggregation rate to that of the control group (р<0,05).
Conclusion. Thus, DI isapromisingcompound for furtherdevelopmentof an antiplatelet drug with new mechanism of action
Bangladesh Journal of Medical Science Vol.18(3) 2019 p.574-576
Collapse
|
|
19
|
Somasundaram SG, Muresanu C, Schield P, Makhmutovа A, Bovina EV, Fisenko VP, Hasanov NF, Aliev G. A Novel Non-invasive Effective Method for Potential Treatment of Degenerative Disc Disease: A Hypothesis. Cent Nerv Syst Agents Med Chem 2019; 19:8-14. [PMID: 30332977 DOI: 10.2174/1871524918666181017152053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2018] [Revised: 10/10/2018] [Accepted: 10/12/2018] [Indexed: 06/08/2023]
Abstract
The pathophysiology of the intervertebral discs plays a significant role in the people's life quality. There is not adequate research done in the pathogenesis and treatment of intervertebral disc degeneration. Alternately, self-educated physiology offers a novel and noninvasive method to reverse the degenerated discs. In this single case study, report attempts have been made to highlight the effect of the self-educative physiology, on magnetic resonance imaging investigations, of progressive healing, on the degenerated intervertebral discs. Based on this novel method, an effort has been made to review literature on the degeneration of intervertebral discs and available mode of treatments and then to propose a hypothesis for the biochemical mechanisms of healing. The idea is that transforming growth factor-β1 from seminal plasma secretions may contribute to releasing the osteogenic protein- 1 which induces nucleus pulposus and annulus fibrosus cells in intervertebral discs for repairs. In addition, the patient's medical history is presented with background information.
Collapse
Affiliation(s)
- Siva G Somasundaram
- Departments of Biology & Health Education, Salem University, 223 West Main Street, Salem, WV 26426, United States
- NAFA LLC, 64 Carolina Ave, Salem, WV 26426, United States
| | - Cristian Muresanu
- Romanian Television, TVR Cluj, 160 Donath Street, Cluj-Napoca, CJ 400293, Romania
| | - Pamela Schield
- School of Education & Athletics, Salem University, Salem, WV 26426, United States
| | - Alfiya Makhmutovа
- Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation
| | - Elena V Bovina
- Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation
| | - Vladimir P Fisenko
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russian Federation
| | - Nusrat F Hasanov
- Neurology Division, Central Sharur District Hospital, Nakhichevan Autonomous Republic, Azerbaijan
| | - Gjumrakch Aliev
- Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, 142432, Russian Federation
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str., 8, Bld. 2, Moscow, 119991, Russian Federation
- "GALLY" International Biomedical Research Consulting LLC., 7733 Louis Pasteur Drive, #330, San Antonio, TX 78229, United States
- School of Health Science and Healthcare Administration, University of Atlanta, E. Johns Crossing, #175, Johns Creek, GA 30097, United States
| |
Collapse
|
|
20
|
Popova EP, Bogova OT, Chandirli SA, Puzin SN, Sychev DA, Fisenko VP. [Influence of amiodarone on the spectral analysis of heart rate variability in patients with atrial fibrillation elderly and senile age.]. Adv Gerontol 2019; 32:1011-1016. [PMID: 32160442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Atrial fibrillation is more common among elderly patients. Number of comorbidities, such as heart failure, coronary heart disease, disorders of the conduction system of the heart increases with age. Atrial fibrillation is a health problem. In developed countries, there is a high prevalence of the disease. The disease affects more than 33 million people worldwide. Spectral analysis of heart rate variability can be successfully used to evaluate the effectiveness of therapy. The use of this method gives an idea of the role of the autonomic nervous system in the regulation of chronotropic function of the heart. These data help to define conditions of manifestation of efficiency of antiarrhythmic drugs. In this study, spectral analysis were studied in patients with different forms of atrial fibrillation. The effect of amiodarone class III antiarrhythmic drug were studied this study. It is shown that the structure of spectrum of heart rate variability in patients with newly diagnosed atrial fibrillation differs significantly from that in patients with disease duration from 6 months to several years on the background of amiodarone.
Collapse
Affiliation(s)
- E P Popova
- I.M.Sechenov First Moscow State Medical University, 2 build. 4 Bolshaya Pirogovskaya str., Moscow 119991, Russian Federation, e-mail:
| | - O T Bogova
- Russian Medical Academy of Continuous Professional Education, 2/1 build. 1 Barrikadnaya str., Moscow 125993, Russian Federation
| | - S A Chandirli
- Russian Medical Academy of Continuous Professional Education, 2/1 build. 1 Barrikadnaya str., Moscow 125993, Russian Federation
| | - S N Puzin
- I.M.Sechenov First Moscow State Medical University, 2 build. 4 Bolshaya Pirogovskaya str., Moscow 119991, Russian Federation, e-mail:
- Russian Medical Academy of Continuous Professional Education, 2/1 build. 1 Barrikadnaya str., Moscow 125993, Russian Federation
- Federal scientific-clinical center of emergency medicine and rehabilitation, 777 d. Lytkino, Solnechnogoskiy distr., Moscow region 141534, Russian Federation
| | - D A Sychev
- Russian Medical Academy of Continuous Professional Education, 2/1 build. 1 Barrikadnaya str., Moscow 125993, Russian Federation
| | - V P Fisenko
- I.M.Sechenov First Moscow State Medical University, 2 build. 4 Bolshaya Pirogovskaya str., Moscow 119991, Russian Federation, e-mail:
| |
Collapse
|
|
21
|
Avetisov SE, Fisenko VP, Zhuravlev AS, Avetisov KS. [Atropine use for the prevention of myopia progression]. Vestn Oftalmol 2018; 134:84-90. [PMID: 30166516 DOI: 10.17116/oftalma201813404184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Given the prevalence of myopic refraction (from 50 to 84% in Asian countries and 35 to 49% in European countries and the United States in young people), the development of methods for monitoring and preventing myopia continues to be an urgent task. One of the directions of pharmacological intervention on the progression of myopia is associated with the use of a non-selective M-cholinoreceptors antagonist - atropine. The review presents the results of studies on various aspects of the potential for topical application of atropine to control the progression of myopia (experimental and clinical data on the mechanism of action, the effectiveness of clinical use, the possible side effects of various concentrations of the drug).The heterogeneity of the data presented does not yet lead to the conclusion that the long-term instillations of atropine are effective in prevention of progressive myopia. In addition, the wide application of this method, for example, in the territory of the Russian Federation, is limited by approved official instruction for the local application of the atropine solution in ophthalmology.
Collapse
Affiliation(s)
- S E Avetisov
- Research Institute of Eye Diseases, 11 A,B, Rossolimo St., Moscow, Russian Federation, 119021; Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 2-4 Bolshaya Pirogovskaya St., Moscow, Russian Federation, 119991
| | - V P Fisenko
- Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 2-4 Bolshaya Pirogovskaya St., Moscow, Russian Federation, 119991
| | - A S Zhuravlev
- Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 2-4 Bolshaya Pirogovskaya St., Moscow, Russian Federation, 119991
| | - K S Avetisov
- Research Institute of Eye Diseases, 11 A,B, Rossolimo St., Moscow, Russian Federation, 119021
| |
Collapse
|
|
22
|
Neganova ME, Klochkov SG, Petrova LN, Shevtsova EF, Afanasieva SV, Chudinova ES, Fisenko VP, Bachurin SO, Barreto GE, Aliev G. Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach. CNSNDDT 2017; 16:351-355. [DOI: 10.2174/1871527315666161107090525] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/10/2016] [Revised: 10/13/2016] [Accepted: 10/25/2016] [Indexed: 11/22/2022]
|
|
23
|
Popova EP, Fisenko VP. [CLASSIFICATION AND PRINCIPLES OF ACTION OF ANTIARRHYTHMIC AGENTS.]. Eksp Klin Farmakol 2016; 79:33-44. [PMID: 29782778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Data on the pathophysiological mechanisms of arrhythmias and the elecrophysiological mechanisms of antiarrhythmic drug action are reviewed. Development of the classification of antiarrhythmic drugs is analyzed.
Collapse
|
|
24
|
Bondarchuk NG, Fisenko VP. [PROFESSOR VLADIMIR V. NIKOLAEV AND RUSSIAN PHARMACOLOGY.]. Eksp Klin Farmakol 2016; 79:33-37. [PMID: 29787670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Various stages of scientific research activity of Prof. Vladimir V. Nikolaev are analyzed. The importance of Prof. Nikolaev's discovery of the two-neuron parasympathetic nervous system and some new methods of pharmacological substances evaluation is shown. Prof. Nikolaev is known as the editor of the first USSR Pharmacopoeia. Peculiarities of pharmacology teaching at the First Moscow Medical institute under conditions of changing social demands are described. Successful research of Prof. Nikolaev with colleagues in studying new mechanisms of drug action and developing original pharmacological substances is summarized.
Collapse
|
|
25
|
Fisenko VP, Bondarchuk NG. [PROFESSOR A. A. SOKOLOVSKY AND EXPERIMENTAL PHARMACOLOGY IN RUSSIA.]. Eksp Klin Farmakol 2016; 79:30-35. [PMID: 29782752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Various stages of the creative activity of Professor A. A. Sokolovsky have been analyzed. Sequential formation of his scientific outlook is shown and the history of creation of his basic hypotheses and ideas about the action of drugs is outlined. Manuals and textbooks on pharmacology, created by Prof. A. A. Sokolovsky, are considered. Peculiarities of teaching pharmacology introduced by Prof. A. A. Sokolovsky at the medical faculty of Imperial Moscow University are discussed.
Collapse
|
|
26
|
Glybochko PV, Fisenko VP. IMMUNOTHERAPY OF BLADDER CANCER. BCG VACCINE: PRINCIPLES OF ACTION, EFFICACY AND SAFETY. Eksp Klin Farmakol 2016; 79:34-43. [PMID: 30085482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Data on the principles of BCG vaccine action on the cancer of bladder are presented. Probable targets for BCG vaccine are estimated. Efficacy of BCG vaccine in non-muscle invasive cancer of bladder is analyzed. Side effects of BCG vaccine are examined. Possibilities of evaluating BCG vaccine usage at low (sub-therapeutical) doses are discussed. Various approaches to reducing the resistance of bladder cancer with respect to BCG vaccine are considered. The perspectives of bladder cancer immunotherapy are outlined.
Collapse
|
|
27
|
Popova EP, Fisenko VP. [EFFICACY OF ANTIARRHYTHMIC AGENTS UNDER CONDITIONS OF STIMULATION OF THE SYMPATHETIC NERVOUS SYSTEM.]. Eksp Klin Farmakol 2016; 79:26-34. [PMID: 29791106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The problem of weakening of the action of antiarrhythmic drugs under conditions of activation of the sympathetic nervous system draws increasing attention of researchers. These conditions are frequently encountered in clinical practice in cases of ischemia, myocardial infarction, and in patients with sustained ventricular arrhythmia. In addition, sympathetic, hyperactivity is a characteristic feature of serious cardiovascular diseases including heart failure. The beta-adrenergic stimulation can significantly modulate the electrophysiological action of antiarrhythmic drugs. There are significant differences in the ability of antiarrhythmic drugs to retain efficacy on the background of sympathetic stimulation. Additional administration of beta-blockers to patients with ventricular tachycardia, cardiac insufficiency, cardiomyopathy and patients after myocardial infarction is highly effective and is worth of addition al investigation. The search for drugs whose effect is not affected by sympathetic stimulation is still topical.
Collapse
|
|
28
|
Fisenko VP, Bondarchuk NG. PROFESSOR MIKHAIL P. NIKOLAEV AND RUSSIAN PHARMACOLOGY. Eksp Klin Farmakol 2016; 79:29-33. [PMID: 30085481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Various stages of life, scientific research and pedagogical activity of Prof. Mikhail P. Nikolaev are considered. The importance of his works in drug evaluation, endocrinological pharmacology, pharmacology of heart and vessels, pathological pharmacology, and discovery of drugs for organotherapy is shown. Prof. M. P. Nikolaev's effort in training research staff and teachers in pharmacology and his own teaching experience in medical and pharmaceutical universities are summarized. The activity of Prof. M. P. Nikolaev in military pharmacology is analyzed. The role of Prof. M. P. Nikolaev in establishing Russian journal Farmakologiya i Toksikologiya (Parmacology and Toxicology) and creating All-Union Scientific Society of Pharmacologists in the USSR is emnhasized.
Collapse
|
|
29
|
Abstract
Long-lasting effects of new Russian psychotropic drugs Noopept and Afobazol on active avoidance conditioning and formation of learned helplessness neurosis were studied on an original experimental model in rats. Noopept eliminated the manifestations of learned helplessness after long-term (21-day) treatment by increasing the percent of trained animals. Afobazol was low effective in preventing manifestations of learned helplessness, but if used for a long time, it reduced the incidence of learned helplessness development by increasing the percent of untrained animals.
Collapse
Affiliation(s)
- A A Uyanaev
- Department of Pharmacology, Therapeutic Faculty, I. M. Setchenov Moscow Medical Academy
| | | |
Collapse
|
|
30
|
Fisenko VP. [Effects of aminoglycoside antibiotics on various structures of the acoustic analyzer]. Eksp Klin Farmakol 2003; 66:42-5. [PMID: 12962047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/04/2023]
Abstract
Aminoglycoside antibiotics decrease the microphone potential amplitude and the auditory nerve potential in response to acoustic stimulation. These drugs suppress the bioelectrical activity of medulla, cerebral cortex, and olivo-cochlear efferent system. The experiments on freely moving cats showed that cortical response to electric stimulation of thalamocortical fibers originating from medial geniculate body are more sensitive to aminoglycoside antibiotics than the microphone potential and the auditory nerve potential.
Collapse
Affiliation(s)
- V P Fisenko
- Department of Pharmacology, Sechenov Medical Academy, ul. Bol'shaya Pirogovskaya 2/6, Moscow, 119881 Russia
| |
Collapse
|
|
31
|
Kinzirskaia IA, Bogush TA, Ostapchuk NV, Fisenko VP. [Hepatotoxic effects of drugs from some pharmacological groups]. Klin Med (Mosk) 2003; 81:11-6. [PMID: 14664165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
The review presents the results of clinical-observations of side hepatotoxic effects of drugs from different pharmacological groups. Based on the data available in the literature, the authors systematized and supplemented the characteristic types of hepatic damages due to the use of drugs in different fields of medicine. The basic mechanisms responsible for the damaging effects of hepatotropic pharmacological agents are considered. The review places a particular emphasis on the major hepatic dysfunctions observed in oncological care when antitumor drugs having different mechanisms of action. This section of the review is supplemented with cases observed in the past years, wherein there are data on the hepatotoxicity of agents from the platin group, the nonsteroidal antiandrogen flutamide, topoisomerase II inhibitors in addition to the well-known alkylating drugs and antitumor antibiotics that have hepatotoxic properties.
Collapse
|
|
32
|
Fisenko VP. Neurochemical relationships in the action of opioid analgesics on cerebral cortex. Bull Exp Biol Med 2001; 132:613-9. [PMID: 11687833 DOI: 10.1023/a:1012528221557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2001] [Indexed: 11/12/2022]
Abstract
The experiments with unrestrained cats showed that opioid analgesics in near-analgesic doses decreased the amplitude of the primary test response recorded in the second sensorimotor zone of the cerebral cortex in 20-150-msec interval between the stimuli applied to thalamocortical fibers radiating from thalamic n. VPL. Application of test substances affecting certain neurotransmitter processes and microionophoretic application of drugs and neurotransmitters to cortical neurons showed that the inhibitory effect of opioid analgesics on cerebral cortex is probably realized through GABA-, serotonin-, beta-adreno-, and cholinergic structures. The excitatory amino acids are also involved into this process.
Collapse
Affiliation(s)
- V P Fisenko
- Department of Pharmacology, Therapeutics, and Medical Prophylactic Faculties, I. M. Sechenov Moscow Medical Academy
| |
Collapse
|
|
33
|
Ivashkin VT, Fisenko VP, Sheptulin AA. [Non-narcotic analgesics, alcohol and liver]. Klin Med (Mosk) 1999; 77:35-7. [PMID: 10599224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
|
|
34
|
Toloknov AV, Vvedenskaia OV, Bol'shakova TD, Buniatian AF, Khitrov NK, Fisenko VP. [Blood corticosterone and resistance to hypoxia during operant learning and development of learned helplessness]. Biull Eksp Biol Med 1999; 128:29-31. [PMID: 10485043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/13/2023]
|
|
35
|
Toloknov AV, Averkina NA, Khitrov NK, Fisenko VP. [Effect of buspirone on the development of acquired helplessness]. Biull Eksp Biol Med 1998; 126:286-8. [PMID: 9805613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
|
|
36
|
Fisenko VP, Guseĭnov NM. [A model for the study of the ototoxic effects of drugs in an experiment]. Vestn Otorinolaringol 1996:25-8. [PMID: 8714047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The authors compared sensitivity of the acoustic analyzer elements to ototoxic drugs in cat experiments. The model proposed assesses primary responses of the brain cortical acoustic zone (BCAZ) to sound stimulation. The drugs effect on the analyzer's periphery was determined from changes in bioelectric responses of the cochlea to sound stimulation (microphone potential, potential of the acoustic nerve action). The arguments are presented for feasibility of using primary BCAZ responses evoked by electric stimulation of thalamocortical radiation fibers coming from the medial geniculate body for examination of the drug effects on the analyzer's cortex. Parallel registration of the above bioelectrical reactions in the same animal for a long time makes it possible to compare sensitivity of different elements of the acoustic analyzer to ototoxic medication.
Collapse
|
|
37
|
Fisenko VP, Kasparov SA. [The mediator spectrum of the action of morphine and the pentapeptide FK 33-824 on the neurons of the cerebral cortex]. Farmakol Toksikol 1991; 54:11-4. [PMID: 1679398] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Morphine and pentapeptide FK 33-824 were shown to reduce spontaneous and evoked neuronal discharges in the IInd somatosensory zone of the cortex on microiontophoretic and intravenous administration of cats. The neurons were identified by electric stimulation of thalamocortical fibers. The agents tested decreased neuronal responses to glutamate and acetylcholine. They failed to change responses to dopamine and enhanced responses to GABA. Morphine and pentapeptide FK 33-824 appeared to decrease slightly the inhibitory neuronal action of serotonin on microiontophoretic administration and increased it when injected intravenously. Beta-adrenoblocker propranolol decreased the inhibitory action of morphine and pentapeptide FK 33-824 on the cortical neurons.
Collapse
|
|
38
|
Fisenko VP. [The effect of barbiturates, sodium oxybutyrate and ketamine on the cycle of primary response recovery in the second somatosensory area of the cerebral cortex]. Farmakol Toksikol 1990; 53:10-3. [PMID: 1964418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Barbiturates (ethaminal sodium and hexenal) injected to freely moving cats were shown to decrease the testing primary response in the second somatosensory cortical zone to the paired electrical stimulation of the thalamocortical fibers. Sodium hydroxybutyrate increased and ketamine failed to change the testing primary response in the second somatosensory cortical zone.
Collapse
|
|
39
|
Fisenko VP. [The neurochemical characteristics of the effect of morphine and pentapeptide FK 33-824 on cerebral cortical excitability]. Farmakol Toksikol 1990; 53:16-20. [PMID: 2253741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
GABA-stimulating agents (muscimol, depakine, aminohydroxyacetic acid), serotonin stimulants (5-hydroxytryptophan, fluoxetine), catecholaminergic stimulants (L-DOPA, apomorphine) and a cholinergic inhibitor (hemicholinium-3) of the brain were found to enhance the inhibitory effect of morphine and pentapeptide FK 33-824 on the cortical excitability of free-moving cats. GABA-negative agents (thiosemicarbazide, bicuculline, picrotoxin), serotonin-negative agents (p-chlorophenylalanine, methysergide), catecholaminergic inhibitors (6-hydroxydopamine, alpha-methyl-p-tyrosine) and cholinergic stimulant (physostigmine) of the brain appeared to decrease the effects of morphine and pentapeptide FK 33-824 on the excitability of the cortex. beta-adrenoceptor blocker propranolol decreased the effects of morphine and pentapeptide FK 33-824 on the cortical excitability, whereas alpha-adrenoblockers (phentolamine, phenoxybenzamine and yochimbine) exerted no effect on their action.
Collapse
|
|
40
|
Guseĭnov NM, Fisenko VP. [Effects of furosemide on the excitability of the cerebral cortex]. Vestn Otorinolaringol 1989:22-5. [PMID: 2588408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The effect of furosemide on primary responses of the acoustic brain cortex of unrestrained cats was investigated. The responses were induced by electrical excitation of fibers of the thalamocortical radiation (TCR) and by sound excitation of various intensity and frequency. Furosemide at a dose of 18 mg/kg (intraperitoneally) did not modify primary responses to single stimulation of TCR fibers or their recovery. This diuretic produced an inhibitory effect on primary responses induced by sound excitation. Primary responses that developed in the acoustic cortex to sounds of a frequency of 10,000 Hz showed the highest sensitivity to furosemide. It was found that long-term (10 days) use of furosemide led to enhanced effects of the drug on primary responses to sound excitation.
Collapse
|
|
41
|
Guseĭnov NM, Fisenko VP, Kasparov SA. [An electrode for recording bioelectrical activity of the cochlea in chronic experiments]. Vestn Otorinolaringol 1989:65-6. [PMID: 2588422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
|
42
|
Kharkevich DA, Fisenko VP, Kasparov SA. [Role of GABA in the action of narcotic analgesics on the spinal cord and cerebral cortex]. Vestn Akad Med Nauk SSSR 1984:42-48. [PMID: 6152100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
|
43
|
Kharkevich DA, Sinitsyn LN, Churiukanov VV, Fisenko VP, Chichenikov ON. [Effect of benzodiazepines on interneuronal transmission in afferent systems and their antagonism with Ro 15-1788]. Farmakol Toksikol 1983; 46:14-9. [PMID: 6138277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
The tranquilizers diazepam and phenazepam inhibited the responses in ventrolateral columns and segmental polysynaptic potentials in the spinal cord evoked by electrical stimulation of somatic nerves. The drugs also inhibited the responses in somavisceral and associative areas of the brain cortex, in specific, associative and nonspecific nuclei of the thalamus and mesencephalic reticular formation evoked by stimulation of visceral and somatic nerves as well as by sound and photostimulation. Diazepam and phenazepam inhibited cortical responses to single and pair stimulation of the fibers of thalamocortical radiation. Ro 15-1788 which is a specific benzodiazepine antagonist promoted the recovery of bioelectrical responses decreased by diazepam and phenazepam. It is suggested that the inhibitory action of diazepam and phenazepam on interneuronal transmission in afferent systems is realized via the involvement of benzodiazepine receptors.
Collapse
|
|
44
|
Machula AI, Barkov NK, Fisenko VP. [Possible experimental equivalent of the hallucinogenic action of drugs]. Biull Eksp Biol Med 1982; 93:60-2. [PMID: 6123354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
|
45
|
Machula AI, Barkov NK, Fisenko VP. [Differentiation by animals of visual signals as affected by benzodiazepine tranquilizers]. Farmakol Toksikol 1982; 45:13-5. [PMID: 6122594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
|
46
|
Aliautdin RN, Kasparov SA, Fisenko VP, Chicehnkov ON. [Effect of opiate peptides on interneuronal transmission in the spinal cord]. Farmakol Toksikol 1981; 44:406-10. [PMID: 6269876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
It has been shown that leucin- and methionine-enkephalins (200 microgram into the lateral brain ventricle), as well as synthetic opiate peptides FK 33-824 (2 mg/kg) and tetrapeptide (25 mg/kg) disturb the excitation transmission in the cat ventrolateral columns. The effects of opiate receptors was more pronounced in animals with the intact central nervous system as compared with spinal animals. Naloxone (1 mg/kg) eliminated the effect of opiate peptides.
Collapse
|
|
47
|
Kharkevich DA, Fisenko VP. The effect of neuromuscular blocking agents on the acetylcholine receptors of different skeletal muscles. Arch Int Pharmacodyn Ther 1981; 251:255-69. [PMID: 6269508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
The comparative sensitivity of acetylcholine receptors of different skeletal muscles--m. masseter, m. gastrocnemius, m. triceps brachii, mm. obliquus et transversus abdominis, mm. intercostales, m. phrenicus to neuromuscular blocking agents was investigated. Experiments were performed on cats anesthetized with urethane (600 mg/kg, i.v.) and chloralose (70 mg/kg, i.v.). Muscle action potentials evoked by electrical stimulation of motor nerves were recorded. Derivatives of alpha-truxillic acid--anatruxonium and cyclobutonium, steroidal neuromuscular blocking agents--pancuronium and pipecurium, decamethonium and succinylcholine and their N-adamantyl analogues--decadonium and diadonium respectively, as well as tubocurarine chloride were tested. It was shown that the succession of relaxation of different skeletal muscles induced by the neuromuscular blocking agents of different chemical structure is variable.
Collapse
|
|
48
|
Fisenko VP, Manula AI. [Action of opiate peptides and narcotic analgesics on the cerebral cortex]. Biull Eksp Biol Med 1980; 90:175-7. [PMID: 6105896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
The chronic experiments on freely moving cats have shown that the opiate peptides, FK33--824 (Tyr--D--Ala--Gly--MePhe--Met(o)--ol) and tetrapeptide (Tyr--D--Ala--Gly--Phe--NH2), as well as the narcotic analgesics, morphine, phentanyl and pentazocine in doses close to analgesic ones, suppress the recovery cycles of primary responses (PR) in the second somatosensory and associative zones of the brain cortex, recorded at paired stimulation of the fibres of thalamo-cortical radiation (TCR). In larger doses these agents slightly increase PR recorded at single stimulation of TCR, provoke the convulsive discharges on EEG and motor excitation of the animals. Naloxon eliminates all the mentioned effects of the tested opiate peptides and narcotic analgesics.
Collapse
|
|
49
|
Machula AI, Barkov NK, Fisenko VP. [Visual discrimination characteristics under the action of psychostimulants]. Farmakol Toksikol 1980; 43:16-9. [PMID: 7379987] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
It was shown in cats by the method of conditioned defensive reflexes that phenamine (0.5 mg/kg), sydnocarb (3 mg/kg) and katinon (1 mg/kg) accelerate realization of the conditioned defensive reflex, but abolish the differentiation of visual stimuli. While producing a similar effect, cocolen (1 mg/kg) does not abolish the differentiation of visual stimuli.
Collapse
|
|
50
|
Polgar AA, Smirnova VS, Fisenko VP. [4-Aminopyridine induced spontaneous synchronism of acetylcholine release in the neuro-muscular junction]. Biull Eksp Biol Med 1979; 88:259-62. [PMID: 519011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
The effect of 4-aminopyridine (4-AP) on acetylcholine release was investigated on the rat phrenic diaphragmatic preparations by means of intracellular recording of spontaneous synaptic activity. 4-AP in concentrations of 1.10(-6) to 1910(-3) M did not cause significant shifts in the mean value of frequency and amplitude of miniature end-plate potentials (MEPP). At the same time 4-AP induced appearance of large spontaneous EPP capable of generating distribution of action potentials. 4-AP transformed the character of MEPP amplitude distribution into the polimodal one, the main node being shifted in several cases to the range of lower values. It was concluded that 4-AP can modify the character of acetylcholine release that intensifies the spontaneous synchronism manifestation.
Collapse
|